Patent AU217758B2 successfully refreshed from Google Patents.
← Back to Patent Explorer
US4017359A Expired / Lapsed US ⏱️ 0.0 years remaining

Production of non-antigenic attenuated viruses

Assignee: Bayer AG
•
Filing: 1974-06-24
•
Granted: 1977-04-12
•
Expires: 1994-06-24
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract There is disclosed novel non-antigenic attenuated viruses which non-specifically stimulate the natural defense mechanism of a host organism with a detectable non-specific induction of interferon; to methods for their production and to their use for the prophylaxis and treatment of viral and bacterial infections in human and veterinary medicine.

Inventors

  • 👤 Otto-Christian Straub

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 21:25
CPC Classifications
C; C12; C12N; C12N7/00; A; A61; A61K; A61K35/00; A61K35/66; A61K35/76; C12N2710/00; C12N2710/00011; C12N2710/16011; C12N2710/16711; C12N2710/16732; C12N2710/16761; C12N2710/16764; Y; Y10; Y10S; Y10S435/00; Y10S435/811

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 87 words
A method of producing an attenuated virus capable of stimulating the natural defense mechanism of a host organism with a detectable non-specific induction of interferon wihtout antigenic effect which comprises passing a virus through a plurality of at least 300 tissue cultures to achieve a degree of attenuation such that antigenic effect cannot be detected in the presence of a detectable non-specific induction of interferon in said organism, wherein said virus is AUJESZKY/pseudo-rabies virus, Influenza virus A1, Influenza virus A1--strain FM1, AUJESZKY/pseudo-rabies virus--strain S/T, or IPV virus.
Claim 2
Independent Claim 87 words
A method of producing an attenuated virus capable of stimulating the natural defense mechanism of a host organism with a detectable non-specific induction of interferon wihtout antigenic effect which comprises passing a virus through a plurality of at least 300 tissue cultures to achieve a degree of attenuation such that antigenic effect cannot be detected in the presence of a detectable non-specific induction of interferon in said organism, wherein said virus is AUJESZKY/pseudo-rabies virus, Influenza virus A1, Influenza virus A1--strain FM1, AUJESZKY/pseudo-rabies virus--strain S/T, or IPV virus.
Claim 3
Dependent Claim 25 words
The method of claim 1 in which each tissue culture passage is of cattle tissue at a temperature in the range of from 36°-40° C.
Claim 4
Dependent Claim 24 words
The method of claim 2 wherein the tissue culture-to-tissue culture transfer takes place over a period of time of from 12 to 100 hours.
Claim 5
Dependent Claim 15 words
The method claim 2 in which the tissue is calf kidney, suprarenal or testicular tissue.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1980-04-11 1980-10-11 1981-04-12 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1984-04-11 1984-10-11 1985-04-12 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1988-04-11 1988-10-11 1989-04-12 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag